<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A non-invasive pulse-wave-velocity Doppler ultrasound technique for the assessment of aortic compliance is described </plain></SENT>
<SENT sid="1" pm="."><plain>A computational approach for correcting for the effect of non-<z:hpo ids='HP_0011010'>chronic</z:hpo> changes in blood pressure is considered and applied to compliance measurements performed on an age-select cohort of 70 normotensive, <z:mpath ids='MPATH_458'>normal</z:mpath> healthy volunteers </plain></SENT>
<SENT sid="2" pm="."><plain>In order to permit the wider availability of the pulse-wave-velocity Doppler ultrasound technique, the authors have developed a MkII system based on a standard 80486/33 MHz <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBM</z:e> compatible WINDOWS based personal computer; real-time spectral analysis being achieved using a relatively inexpensive but fast analogue to digital signal processing card </plain></SENT>
<SENT sid="3" pm="."><plain>An overview of the new apparatus is provided and verification work to compare the repeatability of the MkI and MkII systems is described </plain></SENT>
<SENT sid="4" pm="."><plain>Medical disorders such as <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, <z:e sem="disease" ids="C0020445" disease_type="Disease or Syndrome" abbrv="">familial hypercholesterolaemia</z:e>, <z:hpo ids='HP_0000824'>growth hormone deficiency</z:hpo>, and <z:e sem="disease" ids="C0013720" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Ehlers-Danlos</z:e> and <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndromes</z:e> have <z:hpo ids='HP_0000001'>all</z:hpo> been shown to affect arterial wall compliance </plain></SENT>
<SENT sid="5" pm="."><plain>We suggest that the in vivo clinical measurement of blood pressure corrected aortic distensibility using the MkII system may be a useful, reproducible, non-invasive tool for assessing such patients' susceptibility to atheromatous <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">arterial disease</z:e> as well as for monitoring their response to therapeutic interventions </plain></SENT>
<SENT sid="6" pm="."><plain>Measurements in the aorta may be especially pertinent since the natural history of fatty streaks there tends to parallel that in the coronary vasculature thereby potentially affording a convenient surrogate estimate of <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> </plain></SENT>
</text></document>